Copeland Capital Management, LLC Novozymes A/S Sponsored Adr (D Transaction History
Copeland Capital Management, LLC
- $5.61 Billion
- Q3 2024
A detailed history of Copeland Capital Management, LLC transactions in Novozymes A/S Sponsored Adr (D stock. As of the latest transaction made, Copeland Capital Management, LLC holds 45 shares of NVZMY stock, worth $2,824. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45Holding current value
$2,824% of portfolio
0.0%Shares
15 transactions
Others Institutions Holding NVZMY
# of Institutions
10Shares Held
31.7KCall Options Held
0Put Options Held
0-
Rhumbline Advisers Boston, MA8.63KShares$541,7440.0% of portfolio
-
Mar Vista Investment Partners LLC Los Angeles, CA5.68KShares$356,4760.02% of portfolio
-
Gofen & Glossberg LLC5KShares$313,8000.01% of portfolio
-
S&Co Inc Boston, MA4.5KShares$282,4200.02% of portfolio
-
Boston Common Asset Management, LLC Boston, MA4.12KShares$258,5080.01% of portfolio
About NOVOZYMES A/S SPONSORED ADR (D
- Ticker NVZMY
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 276,303,008
- Market Cap $17.3B